• Sourcing Solutions
  • Services & Membership
  • Help & Community

Quick Details

  • CAS No.: 128270-60-0
  • Other Names: Bivalirudin Peptide
  • MF: NA, C98H138N24O33
  • EINECS No.: NA
  • Place of Origin: Guangdong, China (Mainland)
  • Purity: 99%min
  • Appearance: White Powder
  • Usage: Custom-Made Peptides
  • Brand Name: Yiyan
  • Model Number: Bivalirudin Peptide
  • Certification: GMP
  • Color: Snow White
  • Packing: Plastic Vial(Dedicated for Peptide Packing) or Gla
  • Grade: Medica Grade
  • Function: Sleep-Inducing
  • Type: Vitamins, Amino Acids and Coenzymes

Packaging & Delivery

Packaging Details: general packing or according to your requirements
Delivery Detail: within 1-2 days
Product Description
Hot sale  Bivalirudin  peptide  128270-60-0  with high quality
AS No.:
128270-60-0
Other Names:
Bivalirudin Trifluoroacetate
MF:
C98H138N24O33
EINECS No.:
128270-60-0
Place of Origin:
Shaanxi, China (Mainland)
Type:
Vitamins, Amino Acids and Coenzymes
Grade Standard:
Medicine Grade
Usage:
Animal Pharmaceuticals
Brand Name:
SGONEK
Model Number:
API
Purity:
99% Min
Product Name:
Bivalirudin Trifluoroacetate
Grade:
Medical Gelatin
Assay:
HPLC 99%
Color:
White fine powder
Specification:
99% HPLC
MSDS:
Available
COA:
Available
Introduction

 

Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin. Bivalirudin is a short, synthetic peptide that is potent, highly specific, and a reversible inhibitor of thrombin.It inhibits both circulating and clot-bound thrombin,while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin has a quick onset of action and a short half-life.It does not bind to plasma proteins (other than thrombin) or to red blood cells. Therefore it has a predictable antithrombotic response. There is no risk for Heparin Induced Thrombocytopenia/Heparin Induced Thrombosis-Thrombocytopenia Syndrome (HIT/HITTS).It does not require a binding cofactor such as antithrombin and does not activate platelets.These characteristics make bivalirudin an ideal alternative to heparin.

Function

  Bivalirudin is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA). Bivalirudin with provisional use of glycoprotein IIb/IIIa inhibitor (GPI) is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention (PCI). Bivalirudin is indicated for patients with, or at risk of HIT/HITTS undergoing PCI. Bivalirudin is intended for use with aspirin and has been studied only in patients receiving concomitant aspirin.

Specification

 

Product Name

Bivalirudin Trifluoroacetate

Cas No.

128270-60-0

Molecular Formula

C98H138N24O33

Molecular Weight

2180.33

Purity (HPLC)

99.0%min.

Appearance 

White powder

Single Impurity (HPLC) 

0.5%max

Amino Acid Composition 

±10% of theoretical

Peptide Content (N%)

≥80.0%

Water Content (Karl Fischer) 

≤8.0%

Acetate Content (HPIC)

≤12.0%

MS (ESI)

Consistent

Mass Balance 

95.0~105.0%

Transaction History of the Supplier

Below is the information about the supplier's transactions conducted via Alibaba.com. If you require further details regarding the transaction data, please contact the supplier directly.

Transaction Overview

Transactions

Transaction Details

This supplier has completedtransactions with buyers from .

Shipping Destination
Transaction Value
Transaction Date
Email to this supplier
Trade Assurance
China (Mainland) | Manufacturer, Trading Company
Transaction Level:
Supplier Assessments:
7 Transactions 20,000+
The supplier’s transactions conduted via Alibaba.com in the past 6 months.
The supplier supports Trade Assurance – A free service that protects your orders from payment to delivery.
Supplier's Trade Assurance Limit: US $27,000
Learn More